← Back to headlines
Swedish Agency TLV Rejects Subsidy for Weight-Loss Drug Wegovy
Sweden's Dental and Pharmaceutical Benefits Agency (TLV) has decided against subsidizing the weight-loss medication Wegovy, a decision confirmed by manufacturer Novo Nordisk.
23 Feb, 12:54 — 23 Feb, 12:55
Moderate (27/100)
2 sourcesNarrow spread1 region
ℹAll sources from Sweden region
ℹOnly 2 sources cover this story
Perspective Analysis
Comparing sources…
How outlets covered this
Right-leaning
No articles
Coverage Timeline
First report: aftonbladet · 23 Feb, 12:54|Full coverage: All 2 sources within 0m|Window: 0m
Left-leaningCenterRight-leaning
Read at source (2 outlets)
svenska-dagbladet1h ago
Beslutet: Wegovy blir inte subventionerat
Fetmaläkemedlet Wegovy blir inte subventionerat, enligt ett beslut från Tandvårds- och Läkemedelsförmånsverket, TLV. Det uppger tillverkaren Novo Nordisk i ett pressmeddelande.
Read full article →aftonbladet1h ago
Nej till subvention för fetmaläkemedel
Tandvårds- och läkemedelsförmånsverket (TLV) säger nej till subvention för fetmaläkemedlet Wegovy.
Read full article →Related Stories
Topchef holder fast i potentiale for vægttabshåb trods nye data
just now
Understanding Pregnancy and Maternity Insurance Policies
4m ago
Polish Minister Announces Enhanced Psychological Support for Emergency Services
6m ago
Polish Public's Understanding and Stigma Regarding Mental Health Professionals
6m ago